Cardiometabolic care is often discussed through the lens of prevalence, cost, and employer burden, but those data points do not fully explain why many people struggle to sustain progress across obesity, hypertension, prediabetes, cholesterol, and other overlapping risks. This webinar will reframe the conversation by focusing on cardiometabolic care as a lived human experience, exploring what happens between office visits, during moments of change, and across multiple conditions at once.
This clinically-grounded discussion will uncover the themes emerging from Omada members' experience in the GLP-1 era and what those insights should mean for employers evaluating cardiometabolic benefit solutions. The conversation will also examine how benefits can complement physician care, why integrated support matters, and how cholesterol management can serve as a useful example of the need for a more connected cardiometabolic strategy.
In this session, the speakers will cover
- Why population-level statistics alone do not explain the day-to-day barriers members face in sustaining cardiometabolic progress.
- What the "between-visit" period reveals about adherence, confidence, habit formation, and the need for more practical support.
- What employers should look for when evaluating cardiometabolic and GLP-1-related solutions, including signs that a program truly complements physician care instead of adding fragmentation.
- How obesity, hypertension, prediabetes, cholesterol, and liver risk are experienced as one interconnected health story rather than separate benefit categories.
- How cholesterol management can be used as a test case for evaluating more integrated and human-centered cardiometabolic support.
